IDIBAPS participates in European Network on antibiotic resistances and hospital infections

February 16, 2007

This release is also available in Spanish.

The MOSAR project (Mastering hOSpital Antimicrobial Resistance and its spread into the community) is the first European-scale work devoted to the control and study of antimicrobial resistance in hospitals. MOSAR is coordinated by the Institut national de la santé e de la recherche médicale (INSERM, Christian Brun-Buisson, unit 657 "Pharmaco-epidemiology and assessment of the impact of health products on populations"), and has about 20 public and private laboratories, and more than 50 hospitals in Europe and Israel. IDIBAPS-Hospital Clínic is the only nationwide representative of the network, and has the participation of the group of Dr. Jordi Vila, head of the Bacteriology Unit of Hospital Clínic, and member of the Public health, epidemiology and international health group of IDIBAPS.

The appearance and spread of resistant bacteria is one of the most alarming events of the last fifty years. This problem is aggravated by the slow pace of design of innovative antibiotics during the last 20 years. This phenomenon is most visible in the framework of hospitals, but general population is also affected, since exchanges between both sectors are increasingly rapid and numerous. Research on the transmission dynamics of four types of microorganisms (methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococcus, Acinetobacter spp. and extended-spectrum-lactamase-producing Enterobacter) will allow a design of strategies to control the appearance and spread of these multiresistant microorganisms.

MOSAR will structure the network in a platform of services in order to establish industrial collaborations with the large private institutions of this field. All MOSAR members are highly involved in the fight against bacterial resistances. MOSAR is a 5-year integrated project, i.e., aiming to emphasize the scientific results. It has been financed with 10 million Euro by the European Commission, within the Seventh Framework Programme for Research And Development (FPRD).

MOSAR's objectives are:

1. To fine tune and to validate fast diagnostic tools permitting the earliest possible identification of multiresistant bacteria and of resistance mechanisms. To identify the risk of propagation of these multiresistant bacteria and to establish strategies of prevention and of more suitable treatments.

2. To put into operation approximations to avoid the appearance and to contain spreading of these resistant bacteria in European hospitals, especially in the units more exposed to this problem (intensive care units, surgery and rehabilitation units).

3. To achieve a better understanding on why some resistant bacteria are easily propagated in hospitals, and be able to identify the epidemic capacities of circulating bacteria.

4. Finally, to conceive tools permitting a better adaptation of the strategies to control the transmission of these bacteria and the use of antibiotics.
Further information please contact:

Institut d'Investigacions Biomèdiques August Pi i Sunyer

Marc de Semir, Head of Communication (
Àlex Argemí, Sientific editor (
Tel.: 93 227 57 00
MOSAR website (soon available):

IDIBAPS - Institut d'Investigacions Biomèdiques August Pi i Sunyer

Related Bacteria Articles from Brightsurf:

Siblings can also differ from one another in bacteria
A research team from the University of Tübingen and the German Center for Infection Research (DZIF) is investigating how pathogens influence the immune response of their host with genetic variation.

How bacteria fertilize soya
Soya and clover have their very own fertiliser factories in their roots, where bacteria manufacture ammonium, which is crucial for plant growth.

Bacteria might help other bacteria to tolerate antibiotics better
A new paper by the Dynamical Systems Biology lab at UPF shows that the response by bacteria to antibiotics may depend on other species of bacteria they live with, in such a way that some bacteria may make others more tolerant to antibiotics.

Two-faced bacteria
The gut microbiome, which is a collection of numerous beneficial bacteria species, is key to our overall well-being and good health.

Microcensus in bacteria
Bacillus subtilis can determine proportions of different groups within a mixed population.

Right beneath the skin we all have the same bacteria
In the dermis skin layer, the same bacteria are found across age and gender.

Bacteria must be 'stressed out' to divide
Bacterial cell division is controlled by both enzymatic activity and mechanical forces, which work together to control its timing and location, a new study from EPFL finds.

How bees live with bacteria
More than 90 percent of all bee species are not organized in colonies, but fight their way through life alone.

The bacteria building your baby
Australian researchers have laid to rest a longstanding controversy: is the womb sterile?

Hopping bacteria
Scientists have long known that key models of bacterial movement in real-world conditions are flawed.

Read More: Bacteria News and Bacteria Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to